1.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
9.42%
7.367
|
6.733 | 6.457 | 7.771 | 8.769 |
| Cost Of Revenue |
22.76%
3.997
|
3.256 | 3.519 | 5.186 | 5.945 |
| Gross Profit |
3.08%
3.37
|
3.477 | 2.938 | 2.585 | 2.824 |
|
|
5.60%
11.91
|
11.28 | 11.40 | 19.60 | 33.95 |
| Benefits Costs and Expenses |
16.76%
15.86
|
13.58 | 9.552 | 23.97 | 40.21 |
| Costs And Expenses |
5.60%
11.91
|
11.28 | 11.40 | 19.60 | 33.95 |
| Operating Income/Loss |
9.46%
-8.538
|
-7.80 | -8.465 | -17.02 | -31.12 |
| Nonoperating Income/Loss |
94.86%
0.049
|
0.953 | 5.37 | 0.82 | -0.317 |
| Income/Loss From Continuing Operations Before Tax |
23.98%
-8.489
|
-6.847 | -3.095 | -16.20 | -31.44 |
| Income Tax Expense/Benefit |
40.00%
0.014
|
0.01 | 0.007 | 0.026 | -0.018 |
| Income/Loss From Continuing Operations After Tax |
24.00%
-8.503
|
-6.857 | -3.102 | -16.22 | -31.42 |
|
|
24.00%
-8.503
|
-6.857 | -3.102 | -16.22 | -31.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
55.13%
5.338
|
3.441 | 2.694 | 67.58 | 52.74 |
| Diluted Average Shares |
55.13%
5.338
|
3.441 | 2.694 | 67.58 | 52.74 |
| Basic Earnings Per Share |
20.10%
-1.59
|
-1.99 | -1.15 | -0.24 | -0.60 |
| Diluted Earnings Per Share |
20.10%
-1.59
|
-1.99 | -1.15 | -0.24 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):